Search by Drug Name or NDC
NDC 00781-3447-95 Angiomax 250 mg/1 Details
Angiomax 250 mg/1
Angiomax is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sandoz Inc. The primary component is BIVALIRUDIN.
Product Information
| NDC | 00781-3447 |
|---|---|
| Product ID | 0781-3447_eddac8ab-ef06-4517-bbed-7ac30cc73df3 |
| Associated GPIs | 83334020202120 |
| GCN Sequence Number | 047325 |
| GCN Sequence Number Description | bivalirudin VIAL 250 MG INTRAVEN |
| HIC3 | M9E |
| HIC3 Description | THROMBIN INHIBITORS,SEL,DIRECT,REVERS-HIRUDIN TYPE |
| GCN | 12258 |
| HICL Sequence Number | 021872 |
| HICL Sequence Number Description | BIVALIRUDIN |
| Brand/Generic | Brand |
| Proprietary Name | Angiomax |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | bivalirudin |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 250 |
| Active Ingredient Units | mg/1 |
| Substance Name | BIVALIRUDIN |
| Labeler Name | Sandoz Inc |
| Pharmaceutical Class | Anti-coagulant [EPC], Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA020873 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00781-3447-95 (00781344795)
| NDC Package Code | 0781-3447-95 |
|---|---|
| Billing NDC | 00781344795 |
| Package | 10 VIAL, SINGLE-USE in 1 CARTON (0781-3447-95) / 1 INJECTION in 1 VIAL, SINGLE-USE |
| Marketing Start Date | 2019-08-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |